{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,4,3]],"date-time":"2022-04-03T13:44:05Z","timestamp":1648993445890},"reference-count":44,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2011,4,1]],"date-time":"2011-04-01T00:00:00Z","timestamp":1301616000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Enfermedades Infecciosas y Microbiolog\u00eda Cl\u00ednica"],"published-print":{"date-parts":[[2011,4]]},"DOI":"10.1016\/j.eimc.2010.09.014","type":"journal-article","created":{"date-parts":[[2011,2,21]],"date-time":"2011-02-21T15:21:48Z","timestamp":1298301708000},"page":"250-256","source":"Crossref","is-referenced-by-count":7,"title":["Neumon\u00eda neumoc\u00f3cica en la era de la vacuna conjugada heptavalente"],"prefix":"10.1016","volume":"29","author":[{"given":"Antoni","family":"Payeras","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aroa","family":"Villoslada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Margarita","family":"Garau","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mar\u00eda","family":"Borras","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antonio","family":"Pareja","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"Beingolea","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mercedes","family":"Garc\u00eda-Gasalla","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.D.","family":"Gallegos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carlos Jos\u00e9","family":"Alonso-Villaverde","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.eimc.2010.09.014_bib0005","doi-asserted-by":"crossref","first-page":"1737","DOI":"10.1056\/NEJMoa022823","article-title":"Decline in invasive pneumococcal disease after the introduction of protein-polysaccharide conjugate vaccine","volume":"348","author":"Whitney","year":"2003","journal-title":"N Engl J Med."},{"key":"10.1016\/j.eimc.2010.09.014_bib0010","doi-asserted-by":"crossref","first-page":"1569","DOI":"10.1086\/518149","article-title":"Changing characteristics of invasive pneumococcal disease in Metropolitan Atlanta, Georgia, after introduction of a 7-valent pneumococcal conjugate vaccine","volume":"44","author":"Albrich","year":"2007","journal-title":"Clin Infect Dis."},{"key":"10.1016\/j.eimc.2010.09.014_bib0015","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1097\/01.inf.0000148930.41928.0d","article-title":"Impact of pneumococcal conjugate vaccine and the severity of winter influenza-like illnesses on invasive pneumococcal infections in children and adults","volume":"24","author":"Shafinoori","year":"2005","journal-title":"Pediatr Infect Dis J."},{"key":"10.1016\/j.eimc.2010.09.014_bib0020","doi-asserted-by":"crossref","first-page":"1784","DOI":"10.1001\/jama.297.16.1784","article-title":"Invasive pneumococcal disease caused by nonvaccine serotypes among Alaska native children with high levels of 7-valent pneumococcal conjugate vaccine coverage","volume":"297","author":"Singleton","year":"2007","journal-title":"JAMA."},{"key":"10.1016\/j.eimc.2010.09.014_bib0025","unstructured":"Centers for Disease Control and Prevention. Invasive pneumococcal disease in children 5 years after conjugate vaccine introduction eight states, 1998\u20132005. MMWR. 2008;57:144\u20138."},{"key":"10.1016\/j.eimc.2010.09.014_bib0030","doi-asserted-by":"crossref","first-page":"1388","DOI":"10.1086\/592972","article-title":"Emergence of Streptococcus pneumoniae serotypes 19A, 6C, and 22F and serogroup 15 in Cleveland, Ohio, in relation to introduction of the protein-conjugated pneumococcal vaccine","volume":"47","author":"Jacobs","year":"2008","journal-title":"Clin Infect Dis."},{"key":"10.1016\/j.eimc.2010.09.014_bib0035","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1111\/j.1469-0691.2006.1502_1.x","article-title":"Invasive pneumococcal disease among children in a health district of Barcelona: Early impact of pneumococcal conjugate vaccine","volume":"12","author":"Calbo","year":"2006","journal-title":"Clin Microbiol Infect."},{"key":"10.1016\/j.eimc.2010.09.014_bib0040","doi-asserted-by":"crossref","first-page":"1346","DOI":"10.1086\/521626","article-title":"Incidence of pneumococcal disease due to non-pneumococcal conjugate vaccine (PCV7) serotypes in the United States during the era of widespread PCV7 vaccination 1998\u20132004","volume":"196","author":"Hicks","year":"2007","journal-title":"J Infect Dis."},{"key":"10.1016\/j.eimc.2010.09.014_bib0045","doi-asserted-by":"crossref","first-page":"18962","DOI":"10.2807\/ese.13.35.18962-en","article-title":"Impact of infant pneumococcal vaccination on invasive pneumococcal diseases in France, 2001\u20132006","volume":"13","author":"Lepoutre","year":"2008","journal-title":"Euro Surveill."},{"key":"10.1016\/j.eimc.2010.09.014_bib0050","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1086\/524660","article-title":"Emergence of invasive pneumococcal disease caused by nonvaccine serotypes in the era of 7-valent conjugate vaccine","volume":"46","author":"Mu\u00f1oz-Almagro","year":"2008","journal-title":"Clin Infect Dis."},{"key":"10.1016\/j.eimc.2010.09.014_bib0055","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1086\/599827","article-title":"Changing epidemiology of invasive pneumococcal disease in Canada, 1998-2007: update from the Calgary-area Streptococcus pneumoniae research (CASPER) study","volume":"49","author":"Kellner","year":"2009","journal-title":"Clin Infect Dis."},{"key":"10.1016\/j.eimc.2010.09.014_bib0060","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1086\/594125","article-title":"Epidemiology of invasive pneumococcal disease among adult patients in Barcelona before and after pediatric 7-valent pneumococcal conjugate vaccine introduction, 1997\u20132007","volume":"48","author":"Ardanuy","year":"2009","journal-title":"Clin Infect Dis."},{"key":"10.1016\/j.eimc.2010.09.014_bib0065","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/S1473-3099(04)00938-7","article-title":"Streptococcus pneumoniae colonisation: the key to pneumococcal disease","volume":"4","author":"Bogaert","year":"2004","journal-title":"Lancet Infect Dis."},{"key":"10.1016\/j.eimc.2010.09.014_bib0070","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1086\/313954","article-title":"Practice guidelines for the management of community-acquired pneumonia in adults","volume":"31","author":"Bartlett","year":"2000","journal-title":"Clin Infect Dis."},{"key":"10.1016\/j.eimc.2010.09.014_bib0075","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1038\/nrmicro1871","article-title":"The role of Streptococcus pneumoniae virulence factors in host respiratory colonization and disease","volume":"6","author":"Kadioglu","year":"2008","journal-title":"Nature Rev Microbiol."},{"key":"10.1016\/j.eimc.2010.09.014_bib0080","doi-asserted-by":"crossref","first-page":"1661","DOI":"10.1086\/424596","article-title":"Tissue-specific contributions of pneumococcal virulence factors to pathogenesis","volume":"190","author":"Orihuela","year":"2004","journal-title":"J Infect Dis."},{"key":"10.1016\/j.eimc.2010.09.014_bib0085","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.1086\/512617","article-title":"Low CD4 T cell immunity to pneumolysin is associated with nasopharyngeal carriage of pneumococci in children","volume":"195","author":"Zhang","year":"2007","journal-title":"J Infect Dis."},{"key":"10.1016\/j.eimc.2010.09.014_bib0090","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.1016\/S0140-6736(09)61114-4","article-title":"Patogenesis, treatment, and prevention of pneumococcal pneumonia","volume":"374","author":"Tom van der Poll","year":"2009","journal-title":"Lancet."},{"key":"10.1016\/j.eimc.2010.09.014_bib0095","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1086\/313716","article-title":"Impact of penicillin susceptibility on medical outcomes for adult patients with bacteremic pneumococcal pneumonia","volume":"30","author":"Metlay","year":"2000","journal-title":"Clin Infect Dis."},{"key":"10.1016\/j.eimc.2010.09.014_bib0100","unstructured":"Pach\u00f3n D\u00edaz J, Caballero Granado FJ. Neumon\u00edas por bacterias grampositivas. Rev Clin Esp. 1994;194 Monograf 4:839\u201346."},{"key":"10.1016\/j.eimc.2010.09.014_bib0105","first-page":"1","article-title":"Neumon\u00eda bacteri\u00e9mica por Streptococcus pneumoniae: estudio prospectivo de 31 casos","volume":"69","author":"Torn\u00e9 Cachot","year":"1987","journal-title":"Med Clin (Barc)."},{"key":"10.1016\/j.eimc.2010.09.014_bib0110","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1001\/archinte.1937.00170200044004","article-title":"Clinical significance of bacteremia in pneumococcic pneumonia","volume":"59","author":"Tilghman","year":"1937","journal-title":"Arch Intern Med."},{"key":"10.1016\/j.eimc.2010.09.014_bib0115","doi-asserted-by":"crossref","first-page":"1608","DOI":"10.1378\/chest.108.6.1608","article-title":"Bacteremic pneumococcal pneumonia. A community hospital experience","volume":"108","author":"Lippmann","year":"1995","journal-title":"Chest."},{"key":"10.1016\/j.eimc.2010.09.014_bib0120","unstructured":"Clinical and Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing; twentieth informational supplement. M100-S20. January. 2010;29:88\u201391."},{"key":"10.1016\/j.eimc.2010.09.014_bib0125","first-page":"237","article-title":"Community-acquired pneumonia: A 7-year descriptive study. Usefulness of the IDSA\/ATS 2007 in the assessment of ICU admission","volume":"34","author":"Sabtier","year":"2010","journal-title":"Med Intensiva."},{"key":"10.1016\/j.eimc.2010.09.014_bib0130","doi-asserted-by":"crossref","first-page":"1866","DOI":"10.1001\/archinte.161.15.1866","article-title":"Nonsevere community-acquired pneumonia: correlation between cause and severity or comorbidity","volume":"161","author":"Falguera","year":"2001","journal-title":"Arch Intern Med."},{"key":"10.1016\/j.eimc.2010.09.014_bib0135","doi-asserted-by":"crossref","first-page":"791","DOI":"10.7326\/0003-4819-137-10-200211190-00007","article-title":"Health care-associated bloodstream infections in adults: a reason to change the accepted definition of communityacquired infections","volume":"137","author":"Friedman","year":"2002","journal-title":"Ann Intern Med."},{"key":"10.1016\/j.eimc.2010.09.014_bib0140","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1001\/archinte.167.13.1393","article-title":"Health care-associated pneumonia requiring hospital admission: epidemiology, antibiotic therapy, and clinical outcomes","volume":"167","author":"Carratal\u00e0","year":"2007","journal-title":"Arch Intern Med."},{"key":"10.1016\/j.eimc.2010.09.014_bib0145","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1097\/MD.0b013e3180421c16","article-title":"Community-acquired pneumonia requiring admission to anintensive care unit: a descriptive study","volume":"86","author":"Marrie","year":"2007","journal-title":"Medicine."},{"key":"10.1016\/j.eimc.2010.09.014_bib0150","doi-asserted-by":"crossref","first-page":"1709","DOI":"10.1086\/498119","article-title":"Antibiotic pre- scription for community-acquired pneumonia in the intensive care unit: Impact of adherence to Infectious Diseases Society of America guidelines on survival","volume":"41","author":"Bod\u00ed","year":"2005","journal-title":"Clin Infect Dis."},{"key":"10.1016\/j.eimc.2010.09.014_bib0155","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1136\/thx.2009.123612","article-title":"Pneumococcal pneumonia presenting with septic shock: host- and pathogen-related factors and outcomes","volume":"65","author":"Garcia-Vidal","year":"2010","journal-title":"Thorax."},{"key":"10.1016\/j.eimc.2010.09.014_bib0160","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1056\/NEJM199508243330802","article-title":"Resistance to penicillin and cephalosporin and mortality from severe pneumococcal pneumonia in Barcelona, Spain","volume":"333","author":"Pallares","year":"1995","journal-title":"N Engl J Med."},{"key":"10.1016\/j.eimc.2010.09.014_bib0165","doi-asserted-by":"crossref","first-page":"612","DOI":"10.4321\/S0212-71992002001200002","article-title":"Neumon\u00eda neumoc\u00f3cica con bacteriemia en adultos: estudio descriptivo en el noroeste de Espa\u00f1a","volume":"19","author":"N\u00fa\u00f1ez Fern\u00e1ndez","year":"2002","journal-title":"An Med Interna (Madrid)."},{"key":"10.1016\/j.eimc.2010.09.014_bib0170","doi-asserted-by":"crossref","unstructured":"Jover F, Cuadrado JM, Andreu L, Mart\u00ednez S, Ca\u00f1izares R, Ortiz de la Tabla V. A comparative study of bacteremic and non-bacteremic pneumococcal pneumonia. Eur J Intern Med. 2008;19:15\u201321.","DOI":"10.1016\/j.ejim.2007.03.015"},{"key":"10.1016\/j.eimc.2010.09.014_bib0175","doi-asserted-by":"crossref","first-page":"2538","DOI":"10.1001\/archinte.161.21.2538","article-title":"A fresh look at the definition of susceptibility of Streptococcus pneumoniae to beta-lactam antibiotics","volume":"161","author":"Musher","year":"2001","journal-title":"Arch Intern Med."},{"key":"10.1016\/j.eimc.2010.09.014_bib0180","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1056\/NEJM199701233360402","article-title":"A prediction rule to identify lowrisk patients with community acquired pneumonia","volume":"336","author":"Fine","year":"1997","journal-title":"N Engl J Med."},{"key":"10.1016\/j.eimc.2010.09.014_bib0185","doi-asserted-by":"crossref","unstructured":"Comit\u00e9 Asesor de vacunas de la Asociaci\u00f3n Espa\u00f1ola de Pediatr\u00eda. La enfermedad neumoc\u00f3cica y su prevenci\u00f3n. Vacuna neumoc\u00f3cica conjugada heptavamente. An Esp Pediatr. 2002;56:79\u201390.","DOI":"10.1016\/S1695-4033(02)77779-5"},{"key":"10.1016\/j.eimc.2010.09.014_bib0190","doi-asserted-by":"crossref","first-page":"1390","DOI":"10.3201\/eid1409.071094","article-title":"Pediatric parapneumonic empyema, Spain","volume":"14","author":"Obando","year":"2008","journal-title":"Emerg Infect Dis."},{"key":"10.1016\/j.eimc.2010.09.014_bib0195","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1086\/518538","article-title":"Association of serotypes of Streptococcus pneumoniae with disease severity and outcome in adults: an international study","volume":"45","author":"Alanee","year":"2007","journal-title":"Clin Infect Dis."},{"key":"10.1016\/j.eimc.2010.09.014_bib0200","doi-asserted-by":"crossref","first-page":"e23","DOI":"10.1086\/600045","article-title":"Invasive pneumococcal disease among adults: associations among serotypes, disease characteristics, and outcome","volume":"49","author":"Jansen","year":"2009","journal-title":"Clin Infect Dis."},{"key":"10.1016\/j.eimc.2010.09.014_bib0205","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1016\/S0140-6736(05)71043-6","article-title":"Georgia Emerging Infections Program. Incidence of macrolide resistance in Streptococcus pneumoniae after introduction of the pneumococcal conjugate vaccine: population-based assessment","volume":"365","author":"Stephens","year":"2005","journal-title":"Lancet."},{"key":"10.1016\/j.eimc.2010.09.014_bib0210","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.1056\/NEJMoa051642","article-title":"Active Bacterial Core Surveillance of the Emerging Infections Program Network. Effect of introduction of the pneumococcal conjugate vaccine on drug-resistant Streptococcus pneumoniae","volume":"354","author":"Kyaw","year":"2006","journal-title":"N Engl J Med."},{"key":"10.1016\/j.eimc.2010.09.014_bib0215","doi-asserted-by":"crossref","first-page":"1668","DOI":"10.1001\/jama.295.14.1668","article-title":"Invasive pneumococcal disease among infants before and after introduction of pneumococcal conjugate vaccine","volume":"295","author":"Poehling","year":"2006","journal-title":"JAMA."},{"key":"10.1016\/j.eimc.2010.09.014_bib0220","unstructured":"Payeras A, Garau M, Villoslada A, Beingolea D, Sevillano A, Borras M, et al. Prevalencia, evoluci\u00f3n y factores cl\u00ednicos relacionados con infecciones por Streptococcus pneumoniae con resistencia a quinolonas. XIV Congreso de la Sociedad de Enfermedades Infecciosas y Microbiolog\u00eda Cl\u00ednica (SEIMC); 19\u201322 mayo 2010; Barcelona, Espa\u00f1a. p 186\u20137."}],"container-title":["Enfermedades Infecciosas y Microbiolog\u00eda Cl\u00ednica"],"original-title":[],"language":"es","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0213005X10004799?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0213005X10004799?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,6,8]],"date-time":"2019-06-08T14:07:57Z","timestamp":1560002877000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0213005X10004799"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,4]]},"references-count":44,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2011,4]]}},"alternative-id":["S0213005X10004799"],"URL":"https:\/\/doi.org\/10.1016\/j.eimc.2010.09.014","relation":{},"ISSN":["0213-005X"],"issn-type":[{"value":"0213-005X","type":"print"}],"subject":[],"published":{"date-parts":[[2011,4]]}}}